| 25 |
Agreement for joint research between LyseNTech and Zoonotic Infectious Disease Research Institute of Chonbuk National University |
LyseNTech |
2024-05-27 |
1022 |
| 24 |
Approval of IND for phase I clinical trial for Endolysin LNT103 |
LyseNTech |
2024-04-03 |
1126 |
| 23 |
LyseNTech selected for the GloPID-R project |
LyseNTech |
2024-04-03 |
1053 |
| 22 |
LyseNTech filed IND for phase 1 clinical trial of its endolysin |
LyseNTech |
2023-11-23 |
1219 |
| 21 |
LyseNTech acquired US patent for endolysin LNT103 |
LyseNTech |
2023-11-22 |
1165 |
| 20 |
LyseNTech won the grand prize at the 2023 Gyeonggi Startup Investment Conference & Global Day |
LyseNTech |
2023-11-03 |
1233 |
| 19 |
Heejoon Myung, CEO of LyseNTech, presented at the 2023 Korean Society of Infectious Diseases |
LyseNTech |
2023-11-03 |
1210 |
| 18 |
Poster presentation in World AMR Congress 2023 (Philadelphia, USA) |
LyseNTech |
2023-09-21 |
1210 |
| 17 |
Oral presentation in The 1st International Symposium for Infectious Diseases Research Institutes Cooperation |
LyseNTech |
2023-09-21 |
1196 |
| 16 |
Oral presentation in 26th Congress of the Asian Pacific Society of Respirology |
LyseNTech |
2023-09-21 |
1229 |
